Arzoxifene versus raloxifene: effect on bone and safety parameters in postmenopausal women with osteoporosis期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Arzoxifene versus raloxifene: effect on bone and safety parameters in postmenopausal women with osteoporosis

Authors:	D.?L.?Kendler author-information" > author-information__contact u-icon-before" > mailto:kendler@ca.inter.net" title=" kendler@ca.inter.net" itemprop=" email" data-track=" click" data-track-action=" Email author" data-track-label=" " >Email author,S.?Palacios,D.?A.?Cox,J.?Stock,J.?Alam,S.?A.?Dowsett,J.?Zanchetta

Affiliation:	(1) University of British Columbia, 600-1285 West Broadway, Vancouver, BC, Canada, V6H 3X8;(2) Palacios Institute of Woman′s Health, Madrid, Spain;(3) Eli Lilly and Company, Indianapolis, IN, USA;(4) Instituto de Investigaciones Metabolicas y Facultad de Medicina, Universidad del Salvador, Buenos Aires, Argentina

Abstract:	Summary Arzoxifene increased bone mineral density and decreased bone turnover to a significantly greater extent than raloxifene. The hot flush incidence was lower with arzoxifene than raloxifene.

Keywords:
本文献已被 SpringerLink 等数据库收录！